Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review

Gamaoun, Rihab

doi:10.26719/2018.24.6.538

Cited by 53 publications

(34 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The level of the knowledge also varies among different populations. The knowledge range tends to be lower in men (31%) than in women (31-65%), whereas that among adolescents is at 20.0%, which needs to be improved urgently (Gamaoun, 2018). A study in Urumqi, China (Tian et al, 2019), showed that local residents have a better understanding of HPV knowledge compared with non-local residents, most of whom came from rural or county towns around Urumqi.…”

Section: Discussionmentioning

confidence: 99%

Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis

et al. 2021

View full text Add to dashboard Cite

Objectives: To investigate the acceptability of human papillomavirus (HPV) vaccination among men who have sex with men (MSM) and its associated factors.Methods: We searched studies written in English in PubMed, EMBASE, and Web of Science with no geographical or time restrictions. We evaluated the quality of the included literature. We calculated the pooled acceptability and performed meta-analysis of selected studies, including factors associated with the acceptability among MSM, using Review Manager (v5.3).Results: The acceptability among the 15 studies (n = 8,658) was 50% (95% CI: 0.27–0.72). The meta-analysis of seven articles (n = 4,200) indicated that having a college or higher degree (OR = 1.62, 95% CI: 1.35–1.95), disclosure of sexual orientation to healthcare professionals (HCPs; OR = 2.38, 95% CI: 1.47–3.86), vaccination with at least one dose for hepatitis A or B (OR = 2.10, 95% CI: 1.42–3.10), awareness of HPV (OR = 1.85, 95% CI: 1.21–2.83), knowledge of HPV (SMD = 0.28, 95% CI: 0.16–0.39), perceived susceptibility to HPV infection (SMD = 0.31, 95% CI: 0.11–0.50), and perceived severity of HPV-related disease (SMD = 0.40, 95% CI: 0.28–0.51) can promote acceptance of HPV vaccines. Meanwhile, people who have had unprotected anal sex or have more sex partners tend to have low acceptance of HPV vaccines.Conclusions: HPV education should be actively promoted according to the factors that influence the acceptability of HPV vaccines among the MSM population. HPV education should be especially aimed at people with low academic qualifications and people with risky sexual behaviors, and should emphasize the aspects of susceptibility to and severity of HPV-related disease. More intervention trials should be conducted to increase the credibility of the results.

show abstract

Section: Discussionmentioning

confidence: 99%

Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…On the other hand, raising awareness among the general population as well as among specific high-risk subpopulations is considered the most effective method to prevent HPV infection. This requires active involvement by the physicians, and specifically the obstetric gynecology, family medicine and primary health care physicians, to promote the vaccine and other preventive measures among the community [21, 22]. However, inadequate knowledge and awareness among physicians about the importance of the HPV vaccine was highlighted as one of the major limitations to successful vaccination programs [23, 24].…”

Section: Introductionmentioning

confidence: 99%

Physician’s knowledge and opinions on human papillomavirus vaccination: a cross-sectional study, Saudi Arabia

Anfinan

2019

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundIn a transition period of prevention strategy against HPV infection and cervical cancer in Saudi Arabia, it becomes necessary to appraise physicians’ preparedness to undertake the inherent actions and responsibilities, by evaluating their knowledge and opinions regarding HPV infection and vaccine.MethodsA cross-sectional study carried out between Jan 2017 and Nov 2018, included 2000 physicians working in 21 public centers from the five regions of Saudi Arabia. A self-administered questionnaire was used to assess physicians’ perception about HPV infection prevalence (1 item), knowledge about HPV infection and vaccine (9 items), and opinions and attitudes toward vaccine (4 items). A knowledge score (range 0–9) was calculated and adequate knowledge was assumed for a score ≥ median. Factors associated with opinions and attitudes were explored and multivariate regression was used to analyze independent factors of inadequate knowledge (score < median).ResultsMajority of the participants replied correctly to all knowledge questions, and 63.0% perceived HPV infection as a frequently encountered infection. Median knowledge score was 8 and 62.0% had adequate knowledge (score ≥ 8). Inadequate knowledge was independently associated with Saudi nationality (OR = 1.51, p = 0.003), practice level (resident: OR = 3.53, p < 0.001; junior OR = 1.67, p = 0.002), and non Ob-Gyne specialty (OR = 5.40, p < 0.001); in addition to disparities across region and age. Among the participants, 7.6% were immunized and 41.2% accepted to receive the vaccine, while majority were favorable to have their children vaccinated (77.6%) and to include HPV vaccine in the local immunization program (69.6%). Self-perceived underexposure to HPV infection (58.5%), lack of knowledge about the vaccine (21.1%) and being sexually inactive (14.7%) were the most frequently reported reasons for refusing the vaccine. Overall negative attitude regarding vaccine was typically associated with male, older, Saudi, senior consultant in other than Ob/Gyn specialty. Inadequate knowledge level as well as lowly perceived prevalence of HPV infection were associated with less favorable attitude to vaccination.ConclusionsMore specific educational interventions are warranted to trigger physicians’ active engagement in the fight against HPV infection and cervical cancer. Such interventions should demystify the HPV vaccine by exposing its efficacy, availability and safety, along with providing practical information about the vaccination procedure and goals to achieve successful prevention strategy.

show abstract

“…In the study populations included in this analysis, a high level of acceptance of the HPV vaccine was observed among people living with HIV, as has been found in other studies. [28][29][30][31][32][33][34][35][36][37][38][39] A number of studies have also found that high HPV vaccine acceptability in men who have sex with men (with or without HIV) was 75%. 33,46 As for women, in a cohort of young female sex workers living with HIV, 100% agreed to apply the first dose of vaccine, while 79% completed the 3-dose schedule.…”

Section: Discussionmentioning

confidence: 99%

“…[26][27][28][29][30][31][32] In low-and middleincome countries diverse groups, including parents of adolescents and MSM, have shown moderate to high HPV vaccine acceptability. [33][34][35][36][37] Health education and vaccine promotion that is considered understandable, pertinent and that addresses rumors or incorrect information as well as social mobilization supporting HPV vaccine implementation are important factors related to HPV vaccine acceptability in low and middle-income countries. [38][39][40][41] Worldwide, healthcare provider recommendation is one of the most important facilitators of HPV vaccine acceptability and uptake.…”

Section: Introductionmentioning

confidence: 99%

“…47 Studies on acceptability provide evidence on barriers and facilitators to vaccination in different populations that can be used to improve HPV vaccine policy development and implementation, such as designing vaccine promotion materials and providing healthcare providers with information about what they can say when having conversations with patients about the HPV vaccine. 36 In the current analysis, our objective was to measure HPV vaccine acceptance in diverse Mexican adult populations, taking into account HIV status.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV

et al. 2018

View full text Add to dashboard Cite

Objective. To measure HPV vaccine acceptance in diverse Mexican adult populations, taking into account HIV status. Materials and methods. A total of 1 329 men and women, with and without HIV, participated in one of three intervention studies, offering HPV vaccination, carried out in the states of Morelos, Tlaxcala and Mexico City; either the bivalent (Morelos n=103, Tlaxcala n=127) or quadrivalent HPV-vaccine (Mexico City n=1 099) was offered. Results. HPV vaccine was accepted by 80.3% of participants; acceptance was higher in people living with HIV than those without (84.4 vs. 78%, p=0.004). Women had greater HPV infection knowledge (p<0.0001) than men and slightly higher (p=0.4) vaccine acceptance. The main reason for vaccine non-acceptance among HIV-positive participants was their doctor recommended they not get vaccinated. Conclusion.

show abstract

Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review

Cited by 53 publications

References 15 publications

Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis

Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis

Physician’s knowledge and opinions on human papillomavirus vaccination: a cross-sectional study, Saudi Arabia

HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV

Contact Info

Product

Resources

About